Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study

NCT02247453 is registered in ClinicalTrials.gov with Fondazione IRCCS Istituto Nazionale dei Tumori, Milano as lead sponsor.

NCT NCT02247453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study
Lead sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2013
Completion date
October 31, 2026
Enrollment
4,119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer